Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacyclics continues to advance multiple clinical development programs with Xcytrin

June 3, 2004

Array BioPharma highlights Q3 FY 2004 developments

June 3, 2004

Caspase -3 and -8 inhibition has therapeutic potential in lung transplantation

June 3, 2004

TAK-779, a novel immunosuppressant prolongs graft survival in mice

June 3, 2004

A novel JAK-3 inhibitor, NC-1153, increases graft survival and induces transplantation tolerance

June 3, 2004

New cannabinoid CB1 antagonists in early development at Pfizer

June 2, 2004

New FAAH inhibitors with potential utility as analgesic agents

June 2, 2004

Novel 5-HT6 receptor ligands identified by Roche scientists

June 2, 2004

Elan patent covers new bradykinin antagonists for pain and other uses

June 2, 2004

Scios researchers describe new p38alpha inhibitors

June 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...